The Geneva Foundation: Company Profile

Background

The Geneva Foundation is a 501(c)(3) non-profit organization established in 1993, dedicated to advancing military medicine through research, development, and education. With over 30 years of experience, Geneva collaborates with various partners to drive innovative medical research and improve healthcare outcomes for U.S. service members, veterans, their families, and the global community.

Key Strategic Focus

Geneva's strategic focus encompasses:

Core Objectives: Advancing military medicine through comprehensive research, development, and educational initiatives.

Areas of Specialization: Federal grant and contract management, clinical trials, education, and military medicine.

Key Technologies Utilized: Biotechnology, biomanufacturing, vaccine and antibody therapeutics, infectious disease research, and neurotechnology.

Primary Markets Targeted: U.S. military personnel, veterans, and the broader global community.

Financials and Funding

Total Funding: Geneva has secured multiple grants and funding rounds, including a $3.3 million grant in June 2014.

Recent Funding Rounds: The most recent funding round was a grant of $3.3 million in June 2014.

Notable Investors: The Department of Health and Human Services and Military Health have been key investors.

Utilization of Capital: The capital is utilized to support military medical research, development of medical technologies, and educational programs for service members and veterans.

Pipeline Development

Geneva supports a diverse range of research programs, including:

Bioprinting and Biofabrication Center: A research and training center focused on bioprinting, biofabrication, biomanufacturing, and point-of-care biotechnology development.

On-Demand Blood Product Development Program: Developing methods and infrastructure for producing transfusion-ready red blood cells and related products onsite to enable transfusion in austere environments.

Tele-Critical Care Network Implementation and Support: Implementing and supporting networked tele-critical care services to extend expert critical care guidance to bedside providers using networked mobile devices.

Clinical Studies of AI-Enabled Handheld Ultrasound: Acquiring clinical data and developing algorithms for handheld ultrasound imaging with real-time machine learning analysis to support rapid triage of lung and trauma injuries.

Smartphone-Based Mental Health Application: Developing a multimedia mobile application delivering personalized coping tools, distraction and relaxation exercises, activity planning, inspirational content, and support contact management.

Technological Platform and Innovation

Proprietary Technologies: Geneva has filed patents in areas such as intensive care medicine, kidney diseases, and membrane technology.

Significant Scientific Methods: Utilizes advanced technologies including 3D bioprinting, bioreactors, functional near-infrared spectroscopy (fNIRS), electroencephalography (EEG), handheld ultrasound with AI/ML image analysis, machine learning for diagnostic imaging, multiplex rapid diagnostic platforms, smartphone-enabled biosurveillance, virtual reality exposure therapy, and audiovisual brainwave stimulation (AVS).

Leadership Team

Elise W. Huszar, MBA: President & Chief Executive Officer.

Matt Rueckert, MA, MBA: Chief Operating Officer.

Allison Connelly, MBA: Director of Marketing and Strategic Communications.

Kristen Bacon: Director of Finance and Accounting.

Rikki Johnson: Human Resources Director.

Lori Dunigan: Director of Procurement Services.

James Hulbert: Director of Client Partnerships.

Kati O'Brien: Senior Director of Business Operations.

Ernesto Tusa: Associate Director of Strategy.

Competitor Profile

Market Insights and Dynamics: The market for military medical research and development is characterized by a focus on enhancing the health and readiness of service members through innovative medical solutions.

Competitor Analysis: Key competitors include organizations such as TerraSond, PMO Global Alliance, and Aerospace Systems Design Laboratory, which also provide research and development services in related fields.

Strategic Collaborations and Partnerships

Geneva collaborates with various stakeholders, including academic institutions, government agencies, and private entities, to advance military medical research and development. These partnerships enhance Geneva's capacity for innovation and expand its capabilities in delivering effective healthcare solutions to service members and veterans.

Operational Insights

Geneva's strategic considerations include maintaining a streamlined process that provides researchers with personal, direct access to knowledgeable professionals. This approach ensures efficient collaboration and the successful advancement of military medical research projects.

Strategic Opportunities and Future Directions

Geneva's strategic roadmap focuses on expanding its research programs, enhancing technological capabilities, and strengthening partnerships to continue advancing military medicine. The organization's commitment to innovation and excellence positions it to achieve future objectives in improving healthcare outcomes for service members and the global community.